State of New Jersey Common Pension Fund D Buys 707 Shares of Humana Inc. (NYSE:HUM)

State of New Jersey Common Pension Fund D raised its holdings in shares of Humana Inc. (NYSE:HUM) by 1.6% during the 3rd quarter, Holdings Channel.com reports. The firm owned 44,158 shares of the insurance provider’s stock after acquiring an additional 707 shares during the quarter. State of New Jersey Common Pension Fund D’s holdings in Humana were worth $13,987,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently modified their holdings of the business. Swedbank AB grew its stake in Humana by 3.0% during the third quarter. Swedbank AB now owns 105,976 shares of the insurance provider’s stock valued at $33,567,000 after acquiring an additional 3,085 shares in the last quarter. Heritage Oak Wealth Advisors LLC bought a new position in Humana in the 2nd quarter valued at $3,456,000. Mandatum Life Insurance Co Ltd grew its position in shares of Humana by 115.4% during the 3rd quarter. Mandatum Life Insurance Co Ltd now owns 14,000 shares of the insurance provider’s stock valued at $4,434,000 after purchasing an additional 7,500 shares in the last quarter. APG Asset Management US Inc. increased its holdings in shares of Humana by 3.0% in the second quarter. APG Asset Management US Inc. now owns 67,669 shares of the insurance provider’s stock worth $25,274,000 after purchasing an additional 1,955 shares during the period. Finally, Sei Investments Co. raised its position in shares of Humana by 0.4% in the first quarter. Sei Investments Co. now owns 61,897 shares of the insurance provider’s stock worth $21,462,000 after buying an additional 264 shares in the last quarter. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Humana Price Performance

HUM stock opened at $288.12 on Monday. The firm has a 50-day moving average of $289.38 and a 200 day moving average of $332.70. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.76 and a quick ratio of 1.76. The company has a market cap of $34.69 billion, a P/E ratio of 25.52, a PEG ratio of 2.28 and a beta of 0.52. Humana Inc. has a 1 year low of $213.31 and a 1 year high of $527.18.

Humana (NYSE:HUM) last announced its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $4.16 EPS for the quarter, beating the consensus estimate of $3.48 by $0.68. Humana had a return on equity of 13.20% and a net margin of 1.18%. The business had revenue of $29.30 billion during the quarter, compared to analyst estimates of $28.66 billion. On average, sell-side analysts forecast that Humana Inc. will post 15.83 EPS for the current year.

Humana Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st will be given a $0.885 dividend. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.23%. Humana’s dividend payout ratio is currently 31.36%.

Analyst Upgrades and Downgrades

Several analysts have weighed in on the company. Piper Sandler cut Humana from an “overweight” rating to a “neutral” rating and lowered their price target for the company from $392.00 to $274.00 in a report on Thursday, October 3rd. Leerink Partners downgraded shares of Humana from an “outperform” rating to a “market perform” rating and lowered their target price for the company from $400.00 to $250.00 in a research note on Wednesday, October 2nd. Sanford C. Bernstein raised shares of Humana from a “market perform” rating to an “outperform” rating and set a $308.00 price target for the company in a research note on Tuesday, October 8th. Royal Bank of Canada decreased their price target on shares of Humana from $400.00 to $265.00 and set an “outperform” rating on the stock in a report on Tuesday, October 8th. Finally, JPMorgan Chase & Co. lifted their price objective on shares of Humana from $332.00 to $396.00 and gave the stock a “neutral” rating in a report on Wednesday, August 21st. Twenty investment analysts have rated the stock with a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $315.86.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.